June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Inhibition in the retinal ON cone pathway is increased in early diabetes
Author Affiliations & Notes
  • Johnnie Moore-Dotson
    University of Arizona, Tucson, Arizona, United States
  • Erika D Eggers
    University of Arizona, Tucson, Arizona, United States
  • Footnotes
    Commercial Relationships   Johnnie Moore-Dotson, None; Erika Eggers, None
  • Footnotes
    Support  This work was supported by R01 EY026027 (EE), NIH 2T32HL7249-36A1 (JMD), a JDRF Innovative Award (EE) and a JDRF Postdoctoral fellowship (JMD).
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1220. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Johnnie Moore-Dotson, Erika D Eggers; Inhibition in the retinal ON cone pathway is increased in early diabetes. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1220.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : There is increasing evidence of retinal neuronal dysfunction in early diabetes. We have previously shown that GABAergic inhibition is decreased in the rod pathway due to reduced GABA release from amacrine cells (AC). GABAergic AC dysfunction may occur across retinal pathways. The purpose of this study is to determine if GABAergic inhibition to cone bipolar cells (BC) is compromised in early diabetes.

Methods : Diabetes was induced in C57BL/6J, transgenic Mito-CFP and Gus-GFP mice by 3 i.p. injections of streptozotocin (STZ, 75mg/kg), and confirmed by blood glucose levels >200 mg/dL. Six weeks post injections, AC function in the cone pathway was tested by recording light-evoked (L) IPSCs from OFF and ON BCs in dark-adapted retinal slices in response to a 30ms full-field light stimulus. Receptor (R) inputs were pharmacologically isolated. The peak amplitude, charge transfer and time to decay to 37% of peak (D37) were measured.

Results : The charge transfer of ON BC L-IPSCs was significantly increased at multiple intensities in diabetic mice (n=11 cells) compared to control mice (n=10, p<0.05). ON BC L-IPSCs from diabetic mice had a slower D37 (p<0.05). Isolated GABAAR-mediated L-IPSCs in diabetic mice (n=3) had on average increased charge transfer and longer D37 compared to control (n=3). There was no significant difference in GABACR-mediated L-IPSC peak amplitude and charge transfer between control (n=5) and diabetic mice (n=5). In the OFF pathway, the D37 of OFF BC L-IPSCs was significantly slower at multiple intensities in diabetic mice compared to control (n=12 for both, p<0.05).There was no significant difference in GABAAR-mediated L-IPSCs of OFF BCs.

Conclusions : Unlike in the rod pathway, inhibition in the cone pathway is increased in early diabetes. In OFF BCs, the slower timing of L-IPSCs was likely due to a change in glycinergic signaling, since there was no difference in isolated GABAAR-mediated L-IPSCs. In ON BCs, elevated inhibition is likely due to increased GABAAR-mediated inhibition, since there is no change in GABACR-mediated inhibition and ON BCs do not express glycine Rs. These results show that aberrant amacrine cell signaling differs across retinal pathways and may underlie changes in retinal electrical signaling in diabetes.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.